Approved Enterprise Formulary
FormWeb QuickStart Questions or Suggestions? Pharmacy Shared Services Center
Show Therapeutic Classes
Hazardous Drugs
QR Code Add Formweb to your mobile device
Android iOS
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Approved Enterprise Formulary
FormWeb QuickStart Questions or Suggestions? Pharmacy Shared Services Center
Search results for:

denosumab

denosumab
Drug Name Form Strength Ambulatory Use Only Ambulatory Restrictions Inpatient Restrictions Non-Formulary
Jubbonti SOLUTION, SUBCUTANEOUS 60 mg/mL      
Prolia SOLUTION, SUBCUTANEOUS 60 mg/mL      
Stoboclo SOLUTION, SUBCUTANEOUS 60 mg/mL      
Osenvelt SOLUTION, SUBCUTANEOUS 120 mg/1.7 mL      
Wyost SOLUTION, SUBCUTANEOUS 120 mg/1.7 mL      
Xgeva SOLUTION, SUBCUTANEOUS 120 mg/1.7 mL      
VIEW MORE metabolic agents, bone resorption inhibitors, miscellaneous bone resorption inhibitors
CLASS
m00358, m00409, m00415
Prolia Generic Name Brand Name
Biosimilar (HFH preferred) denosumab-bbdz Jubbonti
Biosimilar (approved alternate)* denosumab-bmwo Stoboclo
Originator product denosumab Prolia

 

Xgeva Generic Name Brand Name
Biosimilar (HFH preferred) denosumab-bmwo Osenvelt
Biosimilar (approved alternate)* denosumab-bbdz Wyost
Originator product denosumab Xgeva

*Alternate biosimilar approved for ambulatory clinics when HFH preferred denosumab biosimilar not covered by insurance.

Last updated: Oct. 1, 2025
UpToDate Lexidrug






This site is intended for the staff of Henry Ford Health.
While others may view accessible pages, Henry Ford Health makes no warranty, express or implied,
as to the use of this information outside of Henry Ford Health.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved